Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Teladoc Health, Inc. Director's Dealing 2021

Jun 2, 2021

31995_dirs_2021-06-02_06a07561-603e-4d7d-86a4-b9015d980ddd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Teladoc Health, Inc. (TDOC)
CIK: 0001477449
Period of Report: 2021-06-01

Reporting Person: GOREVIC JASON N (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-01 Common Stock S 10000 $153.34 Disposed 465970 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 50000 Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.

F2: The shares are held of record by the Jason N. Gorevic Grantor Retained Annuity Trust for which the reporting person serves as trustee.